Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Dicloxacillin sodium; dicloxacillin
Alphapharm Pty Ltd
Medicine Registered
DISTAPH _contains the active ingredient dicloxacillin (sodium)_ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Distaph. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking Distaph against the benefits expected for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH YOUR MEDICINE. You may need to read it again. WHAT DISTAPH IS USED FOR Distaph is used to treat infections in different parts of the body caused by bacteria. Distaph is an antibiotic that belongs to a group of medicines called penicillins. These medicines work by killing the bacteria that are causing your infection. Distaph will not work against infections caused by viruses, such as colds or flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY DISTAPH HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed Distaph for another purpose. Distaph is not recommended for use in newborn infants as its safety and effectiveness have not been established in this age group. Distaph is available only with a doctor's prescription. There is no evidence that Distaph is addictive. BEFORE YOU TAKE DISTAPH _WHEN YOU MUST NOT TAKE IT_ DO NOT TAKE DISTAPH IF YOU HAVE HAD AN ALLERGIC REACTION TO: • medicines containing dicloxacillin or any other penicillin e.g amoxycillin • cephalosporin antibiotics • any of the ingredients listed at the end of this leaflet Some of the symptoms of an allergic reaction may include skin rash, itching or hives, swelling of the face, lips, mouth, throat or other parts of the body, shortness of breath, wheezing or troubled breathing. CHECK WITH YOUR DOCTOR OR PHARMACIST IF YOU ARE NOT SURE ABOUT ANY OF THE ABOVE. DO NOT TAKE DISTAPH IF THE EXPIRY DATE (EXP.) PRINTED ON THE BOTTLE HAS PASSED If you take this medicine after the expiry date, it may Read the complete document
DISTAPH _Dicloxacillin (sodium) _ PRODUCT INFORMATION NAME OF THE MEDICINE The active ingredient of Distaph capsules is dicloxacillin (as dicloxacillin sodium). Dicloxacillin sodium is the monohydrate sodium salt of dicloxacillin. The chemical name for dicloxacillin sodium is (6R)-6-[3-(2, 6-dichlorophenyl)-5-methylisoxazole-4-carboxamido]-penicillanate. The structural formula for dicloxacillin sodium is: Molecular Formula: C 19 H 16 Cl 2 N 3 NaO 5 S,H 2 O Molecular Weight: 510.3 CAS Registry No: 13412-64-1 DESCRIPTION Dicloxacillin sodium is an antibiotic and a member of the isoxazolyl penicillins. Dicloxacillin sodium is a white or almost white, crystalline powder. It is hygroscopic, freely soluble in water, soluble in alcohol and in methanol. Each capsule contains dicloxacillin sodium equivalent to 250 mg or 500 mg dicloxacillin. The inactive ingredients present are silica – colloidal anhydrous, magnesium stearate, gelatin, titanium dioxide, sodium lauryl sulfate, water – potable, TekPrint SW-9008 (ARTG No: 2328) and TekPrint SW-9009 (ARTG No: 2343). PHARMACOLOGY Dicloxacillin sodium is a semisynthetic penicillin that resists inactivation by staphylococcal β-lactamase (penicillinase). Penicillinase resistant penicillins exert a bactericidal action against penicillin-susceptible microorganisms during active multiplication. All penicillins inhibit the biosynthesis of the bacterial cell wall. PHARMACOKINETICS _Absorption_. Dicloxacillin is resistant to inactivation by gastric acid and is rapidly absorbed from the gastrointestinal tract. Bioavailability after oral dosing to fasting adults has been reported to range from 50 to 94% with peak levels occurring 1 to 2 hours post administration. The bioavailability of dicloxacillin is decreased in the presence of food. Serum levels after oral administration are directly proportional to dosage at Read the complete document